,
Vasunilashorn, Sarinnapha M.
Ngo, Long H.
Dillon, Simon T.
Fong, Tamara G.
Carlyle, Becky C.
Kivisäkk, Pia
Trombetta, Bianca A.
Vlassakov, Kamen V.
Kunze, Lisa J.
Arnold, Steven E.
Xie, Zhongcong
Inouye, Sharon K.
Libermann, Towia A.
Marcantonio, Edward R.
Funding for this research was provided by:
National Institute on Aging (P01AG031720, K01AG057836, R03AG061582, R24AG054529, R01AG041274, R21AG048600, R01AG051658, K24AG035075)
Alzheimer's Drug Discovery Foundation
Alzheimer's Association (AARF-18-560786)
Article History
Received: 24 November 2020
Accepted: 30 March 2021
First Online: 30 April 2021
Declarations
:
: The Institutional Review Board of Partners Healthcare System (Massachusetts General Hospital, Brigham and Women’s Hospital, Brigham and Women’s Faulkner Hospital) approved all study procedures, with ceded review from Beth Israel Deaconess Medical Center and Hebrew SeniorLife, the study coordinating center.
: Not applicable.
: The authors declare that they have no competing interests.